Evidence map›Paper›PMID 38588469›Full record

ReviewChembiochem : a European journal of chemical biology2024

Reading and Writing the Ubiquitin Code Using Genetic Code Expansion.

Rishi S Patel, Nipuni M Pannala, Chittaranjan Das

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. The Multifaceted Ubiquitination of BIK1 During Plant Immunity inInternational journal of molecular sciences · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rishi S PatelDepartment of Chemistry, Purdue University, 560 Oval Dr., West Lafayette, IN 47907, USA.ORCID 0000-0002-4159-113X
Nipuni M PannalaDepartment of Chemistry, Purdue University, 560 Oval Dr., West Lafayette, IN 47907, USA.
Chittaranjan DasDepartment of Chemistry, Purdue University, 560 Oval Dr., West Lafayette, IN 47907, USA.ORCID 0000-0002-0567-7753

Funding

Mechanism of atypical ubiquitination and deubiquitination by bacterial effectorsR01GM126296 · NIGMS · PURDUE UNIVERSITY · PI Chittaranjan Das · 2018 to 2026
$3.6M
Investigations into ubiquitin binding proteins using structure guided reactivityF31CA275390 · NCI · PURDUE UNIVERSITY · PI PATEL, RISHI · 2022 to 2024
$143k
National Health Institute's NCI and NIGMS 1F31CA275390National Health Institute's NCI and NIGMS 5R01GM126296NCI NIH HHS F31 CA275390NIGMS NIH HHS R01 GM126296
6 · The paper itself

Abstract

Deciphering ubiquitin proteoform signaling and its role in disease has been a long-standing challenge in the field. The effects of ubiquitin modifications, its relation to ubiquitin-related machineries, and its signaling output has been particularly limited by its reconstitution and means of characterization. Advances in genetic code expansion have contributed towards addressing these challenges by precision incorporation of unnatural amino acids through site selective codon suppression. This review discusses recent advances in studying the 'writers', 'readers', and 'erasers' of the ubiquitin code using genetic code expansion. Highlighting strategies towards genetically encoded protein ubiquitination, ubiquitin phosphorylation, acylation, and finally surveying ubiquitin interactions, we strive to bring attention to this unique approach towards addressing a widespread proteoform problem.

Indexed as

Genetic CodeUbiquitinUbiquitinationHumansPhosphorylationUbiquitingenetic code expansionpost-translational modificationsproteoformubiquitin

Identifiers

PMID38588469
PMCPMC11161312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.